MENU

ADAP Adaptimmune Therapeutics plc Forecast, Technical & Fundamental Analysis

a manufacturer of vaccines and cancer immunotherapy products

Industry Biotechnology
ADAP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
ADAP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ADAP is expected to report earnings to rise 403.33% to -15 cents per share on August 07

Adaptimmune Therapeutics plc ADAP Stock Earnings Reports
Q2'24
Est.
$-0.15
Q1'24
Beat
by $0.12
Q4'23
Beat
by $0.13
Q3'23
Beat
by $0.14
Q2'23
Beat
by $0.16
The last earnings report on May 15 showed earnings per share of -2 cents, beating the estimate of -15 cents. With 1.05M shares outstanding, the current market capitalization sits at 329.67M.
A.I. Advisor
published General Information

General Information

a manufacturer of vaccines and cancer immunotherapy products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
60 Jubilee Avenue
Phone
+44 1235430000
Employees
449
Web
https://www.adaptimmune.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EISGX17.550.17
+0.98%
Eaton Vance Small-Cap I
FIZRX35.990.26
+0.73%
Delaware Opportunity R
ECSTX25.500.05
+0.20%
Eaton Vance Large-Cap Value C
FNDMX11.40-0.09
-0.78%
Fidelity Series Sust Non-US Dev Mrkt Fd
TILHX26.60-0.31
-1.15%
Nuveen Large Cap Growth I

ADAP and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ADAP has been loosely correlated with CRSP. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ADAP jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADAP
1D Price
Change %
ADAP100%
+4.88%
CRSP - ADAP
36%
Loosely correlated
+3.94%
ORMP - ADAP
36%
Loosely correlated
-1.36%
ENTA - ADAP
34%
Loosely correlated
+2.06%
NUVB - ADAP
32%
Poorly correlated
+2.22%
ALT - ADAP
31%
Poorly correlated
+6.46%
More